ASCO Metastatic Castration-Resistant Prostate Cancer Guideline Patient Education - Guideline Central
Overview and Background
Treatment Overview
Specific Treatment Options for Patients with mCRPC with Disease Progression Following ADT
Monitoring

Metastatic Castration-Resistant Prostate Cancer

Patient Summary

American Society of Clinical Oncology


Publication Date: May 2, 2025

Source Citation

Taplin M, Riaz IB, Rumble RB, et al. Systemic Therapy in Men with Metastatic Castration Resistant Prostate Cancer: ASCO Living Guideline Update, Version 2025.1. J Clin Oncol. 2026 Jan 20. doi: 10.1200/JCO-25-02693


Garje R, Riaz IB, Naqvi SA, et al. Systemic Therapy in Men with Metastatic Castration Resistant Prostate Cancer: ASCO Guideline Update. J Clin Oncol. 2025 May 2. doi: 10.1200/JCO-25-00007

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.